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Retinitis pigmentosa (RP) represents a genetically heterogeneous group of retinal dystrophies 
affecting mainly the rod photoreceptors and in some instances also the retinal pigment epithelium 
(RPE) cells of the retina. Clinical symptoms and disease progression leading to moderate to severe 
loss of vision are well established and despite significant progress in the identification of causative 
genes, the disease pathology remains unclear. Lack of this understanding has so far hindered 
development of effective therapies. Here we report successful generation of human induced 
pluripotent stem cells (iPSC) from skin fibroblasts of a patient harboring a novel Ser331Cysfs*5 
mutation in the MERTK gene. The patient was diagnosed with an early onset and severe form of 
autosomal recessive RP (arRP). Upon differentiation of these iPSC towards RPE, patient-specific RPE 
cells exhibited defective phagocytosis, a characteristic phenotype of MERTK deficiency observed 
in human patients and animal models. Thus we have created a faithful cellular model of arRP 
incorporating the human genetic background which will allow us to investigate in detail the disease 
mechanism, explore screening of a variety of therapeutic compounds/reagents and design either 
combined cell and gene- based therapies or independent approaches.
Retinitis pigmentosa (RP; OMIM 268000) with a prevalence of 1 in 3,500 individuals is the most com-
mon form of hereditary retinal disorder affecting the working age group. RP is characterized by pro-
gressive dysfunction and death of mainly the rod photoreceptor cells (PR) of the retina however in some 
cases retinal pigment epithelium (RPE) cells are also involved, often resulting in permanent blindness. So 
far 54 genes have been implicated in this disease coding for proteins involved in a myriad of functions 
such as phototransduction signaling cascade, retinoid cycle, cell-cell adhesion or the cytoskeleton1. The 
disease is inherited in all there Mendelian forms, the autosomal recessive (arRP) being the most common 
with over 50% of cases. Largely due to the high genetic heterogeneity and unavailability of disease tissue, 
pathology of the disease remains elusive.
Patient-derived induced pluripotent stem cells (iPSCs) provide an unprecedented opportunity to reca-
pitulate disease pathogenicity without the need for genetic manipulation and creation of gene targeted 
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animal models. Human iPSCs, similar to embryonic stem cells (ESC), can be expanded indefinitely in 
vitro and differentiated into any type of mature cell in the human body, without the ethical and immu-
nogenicity issues associated with ESC2. These cells are also valuable for developing therapeutic strategies, 
drug toxicity screens and development of disease models, in addition to providing a source for cell 
transplantation therapy. RPE cells and photoreceptors (PR) have been successfully generated from iPSCs 
(iPSC-RPE and iPSC-PR respectively) by various groups in stepwise differentiation protocols mimicking 
retinal development by introducing Wnt signaling inhibitors (DKK1), Nodal antagonist Lefty A, Notch 
pathway inhibitor (DAPT-gamma secretase inhibitor), or IGF-13–5. In contrast, only RPE cells have been 
generated spontaneously in overgrown iPSC/ESC cultures without the addition of exogenous factors, 
since derivatives of neuroectoderm appear by default in non-induced cultures6,7. Generated RPE cells in 
these studies display a fully mature phenotype and physiological activity in vitro such as phagocytosis, 
secretion of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) 
and epithelial barrier formation. Cellular models of hereditary retinal dystrophies have been successfully 
created in vitro in Best disease, and RP where patients’ fibroblasts were reprogrammed to iPSC and 
then converted to RPE8,9 or photoreceptor cells10, expressing the disease phenotype. iPSC- derived RPE 
(iPSC-RPE) cells have also been shown to have a protective effect when injected sub-retinaly into the Royal 
College of Surgeons (RCS) rats11 and RPE65-defective mice12. Moreover, iPSCs have met clinical-grade 
requirements13 as a source of RPE grafts and have recently been injected in patients affected by the 
exudative form (wet-type) of age-related macular degeneration (AMD)14. It has been argued that in this 
form of AMD the dysfunction and loss of RPE cells is the main cause of visual impairment in the elderly.
Mer tyrosine kinase receptor (MERTK) belongs to the Tyro3/Axl/Mer (TAM) receptor tyrosine kinase 
family of proteins distinguished by a conserved intracellular kinase domain and extracellular adhesion 
molecule-like domain. TAM receptors regulate a variety of processes such as cell proliferation/survival, 
adhesion, migration, inflammatory response, in a cell- microenvironment- and ligand- specific manner15. 
In previous studies MERTK was found to be disrupted in RCS rats16,17, a classic model for retinal degen-
eration inherited as an autosomal recessive trait, and found to cause early- onset retinitis pigmentosa in 
patients18. RPE cells fail to phagocytize the shed outer segment (OS) material of PR, a circadian activ-
ity performed by RPE cells which serves to renew the damaged lipid and protein components of light 
exposed PR, while new membranous discs are formed (disc biogenesis) and inserted in the basal part of 
the OS. As a result, RCS rats exhibit OS associated debris accumulation in the subretinal space, abnormal 
OS length, eventually leading to the onset of PR degeneration by the P20 stage. Usually complete degen-
eration occurs by P60. Similar phenotype is observed in merkd mice19 indicating that the RPE phagocytic 
defect is the underlying molecular mechanism of disease in humans carrying MERTK mutations. Indeed, 
the reduced retinal thickness and debris detected in the sub-retinal space in patients harboring the 
MERTK –splice-site -mutation resembles the observed phenotype in the RCS rat20. The distinctive clini-
cal presentation of RP is the only disease manifestation of patients harboring MERTK mutations without 
any systemic disease or defects of phagocytosis by macrophages, indicating a specialized function of this 
protein in the RPE cells. In contrast to the detailed clinical understanding of the disease, the mechanism 
by which MERTK acts during the phagocytosis remains partially unveiled. Outer segments are known 
to bind to the integrin receptor α vβ 521 followed by focal adhesion kinase (FAK) activation in the apical 
membrane of RPE22 while the MERTK activation occurs via Gas6/Protein S, TUB, TULP1 ligand bind-
ing23,24. The latter is thought to activate autophosphorylation at tyrosine Y-749, Y-753 and Y-754 in the 
tyrosine kinase domain, which in turn activates the molecular cascade targeting actin or non-muscle 
myosin II to coordinate the cytoskeletal rearrangements necessary for phagocytic ingestion25.
In this study we describe the generation of an in vitro model of RP caused by the mutation of MERTK 
gene using human iPSC technology. We report the generation of a cellular model of MERTK-associated 
RP, which recapitulates the disease phenotype described in animals and in patients and provides a tool 
to advance our understanding of the signaling pathways activated by MERTK. Importantly this can be 
studied in detail in the context of the human genetic background, a crucial feature of the cellular model. 
Equally important is that it provides us with a unique opportunity for the testing of novel therapeutic 
agents in the presence of the human background, which has the potential to significantly reduce the cost 
of preclinical studies in animal models. The derivation of iPSCs from a RP patient’s fibroblasts and the 
generation of a RPE cell line expressing the molecular defect makes an important contribution in our 
ability to undertake translational research.
Results
RP caused by MERTK gene mutation. Skin punch biopsies were taken from a phenotypically 
well-characterized RP patient and an unaffected individual after the signing of informed consent. Forty-
five- year-old patient born of a consanguineous marriage (patient II:2; family RP-0503, Supplementary 
Fig. S1A) was diagnosed with early-onset autosomal recessive RP (arRP). Genome-wide linkage anal-
ysis using the Illumina HumanCyto-12 SNP array followed by homozygosity mapping was performed 
in this Spanish family with 3 affected and 2 unaffected siblings that revealed a large region of 32 Mb 
with a maximum logarithm of the odds (LOD) score of 3.6 on chromosome 2 encompassing MERTK. 
Sequence analysis allowed identification of a novel homozygous frameshift mutation c.992_993delCA 
(p.Ser331Cysfs*5) in MERTK, segregating with the disease in the family (Supplementary Fig. S1A).
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All affected members of this family were diagnosed suffering from RP during the first decade of life. 
Patient II:2 complained of night blindness, loss of peripheral visual field and visual acuity (VA) at the age 
of 7. Ophthalmological examination at 32 years of age showed severe constriction of visual fields in both 
eyes and loss of VA to 20/70 in right eye and finger counting in the left eye. The fundus showed typical 
changes of RP with pale disc, narrowed retinal vessels and bone-spicule pigmentations in the peripheral 
retina. For this study, a healthy individual unrelated to this family and no family history of blindness was 
taken as a healthy control. The healthy individual had a VA of 20/20 at the time of skin biopsy.
Primary fibroblast cell lines were established from the patient II:2 and healthy individual in par-
allel and subjected to direct genomic sequencing to confirm the genotype (Fig.  1A). The deletion 
c.992_993delCA was confirmed in the patient’s DNA. The MERTK gene is composed of 19 coding exons 
with two immunoglobulin-like C2-type (Ig-like) domains, two fibronectin type III (FN3)-like domains, 
a transmembrane (TM) domain and a tyrosine kinase (TK) domain (UniProt Q12866). The deletion of 
CA in exon 7 (NM_006343.2), at position 992_993 causes the frameshift resulting in a premature stop 
codon at position 335 (Supplementary Fig. S1B). The predictive stop codon results in a truncated protein 
with 2 Ig-like domains and part of the first FN3-like domain with no kinase activity (Fig. 1B).
Generation of iPSC from healthy individual and RP patient. The primary fibroblasts derived 
from the skin biopsies were expanded for three to-five passages before being reprogrammed by a Sendai 
viral construct containing four genes: Oct3/4, Sox2, Klf4 and cMyc (Supplementary Fig. S2A). This con-
struct described as highly efficient in transduction was selected for being non-integrative and replication 
deficient. Thirty days after transduction, iPSC colonies were selected by their morphology (refractive 
edges, high nuclear/cytoplasmic ratio) and in situ staining of pluripotency markers (TRA-1-60 or TRA-
1-81). Three iPSC lines per individual were sub-cultured and analyzed at cellular and genetic level to 
confirm successful reprogramming. Pluripotency was assessed by immunocytochemistry for pluripo-
tency markers such as octamer-binding transcription factor 4 (OCT4), NANOG, SRY (sex determining 
region Y)-box 2 (SOX2), and in situ staining to TRA-1-81. The alkaline phosphatase is known to be more 
active in iPSCs and the colorimetric assay depicting its activity confirmed that the selected iPSC colonies 
are indeed pluripotent (Supplementary Fig. S3A). To test the ability of generated iPSC lines to generate 
derivates of three germ layers in vivo, the iPSCs were transplanted subcutaneously into the immunode-
ficient (SCID) mice. Eight weeks after injection, tumor was formed and extracted. Histological sections 
showed that the tumor contained derivatives of all three germ layers including gut-like tissues (endo-
derm), neural cells and retina (ectoderm) and striated muscle, bone, cartilage and adipose tissue (mes-
oderm) (Supplementary Fig. S3B). The healthy individual’s iPSCs were indistinguishable from patient’s 
iPSCs with respect to pluripotency characterization. All selected lines were transgene-free at passages 
7–10 and karyotypically normal over 30 passages (Supplementary Fig. S2B and C, respectively). DNA 
Figure 1. (A). MERTK DNA sequence chromatogram around c.992_993 in healthy and affected patient 
carrying a deletion of CA (c.992_993delCA). DNA sequencing, performed on healthy and patient’s dermal 
fibroblasts and iPSCs’ gDNA, confirmed the mutation in early-onset RP patient. (B). The wild type sequence 
codes for 999 amino acid protein with Immunoglobulin Ig-like C2-type (Ig-like) (residues 100–194 and 
203–281), fibronectin type III-like (FN3) (residues 284–368 and 384–470) transmembrane (TM) (residues 
502–524) and kinase domain (residues 587–854). The mutation results in a predictive truncated protein of 
334 amino acids with expected molecular weight of 36.6 kDa.
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fingerprinting was performed with iPSC lines and proved their genetic identity to parental fibroblasts 
(Supplementary Fig. S2D).
Differentiation of iPSCs into RPE cells. We induced patient’s and the healthy individual’s iPSCs 
to differentiate toward RPE cells in parallel, by removing the pluripotency factor bFGF and culturing 
the cells in suspension until dark patches appeared in the floating aggregates as previously described6 
(Supplementary Fig. S4). The pigmented areas of the aggregates were mechanically excised, trypsinized 
and plated as a monolayer cell culture. After 3–4 weeks in culture the iPSC-derived RPE (iPSC-RPE) cells 
appeared to exhibit polygonal, cobblestone-like morphology, which is characteristic of mature RPE cells. 
The areas with correct morphology were lifted and reseeded on permeable culture inserts to yield a uni-
form cellular monolayer. To reach full functional maturity, the cells were cultured for additional 30–80 
days until high pigmentation. Figure  2A,B depicts the mature iPSC-RPE cells from both individuals 
showing indistinguishable polygonal morphology and pigmentation. Toluidine blue staining (Fig. 2C,D) 
Figure 2. Differentiation of healthy and MERTK p.Ser331Cysfs*5 iPSCs into RPE cells. Bright field 
micrograph of healthy (A) and MERTK p.Ser331Cysfs*5 (B) iPSC-RPE showing typical RPE morphology, 
polygonal shape and pigmentation. Semithin sections of iPSC-RPE cells stained with toluidine blue. Both 
healthy (C) and MERTK p.Ser331Cysfs*5 (D) iPSC-RPE cells form a monolayer of cuboid cells highly 
polarized with abundant apical microvilli (arrows) and melanosomes (arrowheads). Electron micrograph of 
cultured iPSC-RPE, healthy (E) and MERTK p.Ser331Cysfs*5 (F,G,H,I). (G) High magnification of melanin 
granules showing different stages of development. (H) Intercellular junctional complexes which include the 
tight junctions, adherens junctions (arrows) and membrane interdigitations (arrowheads). (I) The basement 
membrane of the cells tightly bound to the transwells support film (arrowheads) and small basal infoldings 
(arrows). A,B scale bar 50µm; C,D scale bar 10µm.
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and transmission electron microscopy of the iPSC-RPE cells (Fig. 2E,F) show that the apical surface of 
the cell monolayer is at the top, where abundant microvilli can be observed. Melanosomes are repre-
sented with black round and oval shapes (Fig. 2G) and have apical distribution. Mitochondria that are 
ellipsoidal in shape and seen below the nuclei are largely displaced toward the basal-lateral part of the 
cells (Fig.  2E,F arrowheads), the natural position for these organelles in vivo. Intercellular junctional 
complexes are visible in appropriately aligned sections of iPSC-RPE of both individuals. The integrity 
and function of the RPE monolayer depend on its basolateral cellular junctions, which include the tight 
junctions, adherens junctions and membrane interdigitations (Fig. 2H). The basement membrane of the 
cells is tightly bound to the transwells support film and small basal infoldings were observed (Fig. 2I).
To validate the identity of generated RPE cells, RT-PCR of selected RPE specific genes was performed 
to compare the expression levels throughout the differentiation process (Fig. 3A,i)). This included mark-
ers such as cellular retinaldehyde-binding protein (CRALBP), Bestrophin 1 (BEST1), retinal pigment 
epithelium-specific protein 65kDa (RPE65), MERTK, and pluripotency marker NANOG. The expression 
profile was compared in healthy and MERTK p.Ser331Cysfs*5 patient’s fibroblasts, two iPSCs lines and 
their respective iPSC-RPE. Figure  3A,i) shows the expected pattern of expression for RPE transcripts 
of BEST1, CRALBP and RPE65 with comparable strong expression levels in iPSC-RPE from both indi-
viduals while, as expected, being absent from iPSCs and fibroblasts. BEST1 was an exception, which 
shows a weak expression in fibroblasts. NANOG, a pluripotency marker, is expressed in iPSCs but 
silenced after the cells differentiate into RPE. The data described in Fig.  3A  (i) were corroborated by 
quantitative analyses (Fig.  3A  (ii)). The expression of RPE specific genes CRALBP, RPE65, BEST1 and 
microphthalmia-associated transcription factor (MITF) are raised over a 1000 fold in iPSC-RPE cells 
from both individuals with respect to the fibroblasts, while CRALBP and RPE65 are just detectable by 
qRT-PCR in iPSCs.
On checking expression of MERTK by RT-PCR using primers spanning exons 14–17 and also by 
qRT-PCR assay using primers spanning exon junction 18–19 (Fig. 3A, Supplementary Fig. S5) indicate 
that MERTK mRNA is detectable in both healthy and MERTK p.Ser331Cysfs*5 iPSCs and rises over 
1000 times with respect to the original fibroblasts in iPSC-RPE of both individuals. MERTK expression 
in iPSC has not been previously described and is in correlation with its expression in human ESC7. 
The level of expression of MERTK in healthy individual was higher than in MERTK p.Ser331Cysfs*5 
patient. The difference in expression pattern of MERTK in iPSC-RPE from healthy individual and RP 
patient is expected since it is known that eukaryotes possess a nonsense-mediated mRNA decay pathway, 
which degrades mRNAs containing nonsense mutations before they are translated into nonfunctional 
polypeptides26. The possibility remains that alternative transcript that does not include the mutation 
site is amplified by the primers and probe used in the assay. In the case that RNA transcribed from 
the c.992_993delCA allele escapes nonsense mediated decay, a truncated protein of 334 amino acids 
(expected size of 36,6 kDa) lacking the kinase domain would be produced. Overall, we can confirm that 
the generated iPSC-RPE cell lines originated from two different individuals exhibit the mature RPE gene 
expression pattern and are indistinguishable at this point.
Immunocytochemical staining revealed a strong expression of the visual cycle markers CRALBP, RPE65, 
as well as BEST1 and zonula-occludens-1 (ZO-1), a tight-junction marker, indistinguishable in both 
individuals (Fig. 3B,i)). Apico-lateral and apical localization of ZO-1 and sodium/potassium-dependent 
ATPase (Na+/K+ ATPase), respectively, is a hallmark of RPE cells and was found in both healthy and 
MERTK p.Ser331Cysfs*5 iPSC-RPE cells (Supplementary Fig. S6).
MERTK expression in iPSC-RPE. Immunocytochemical detection of MERTK in iPSC-RPE mon-
olayer from healthy individual showed its expression apically as previously described27 (Fig.  3B,ii)). In 
contrast, iPSC-RPE cells derived from the RP patient carrying the mutation p.Ser331Cysfs*5 are com-
pletely deficient in MERTK (Fig.  3B,ii)). The antibody used detected the N-terminal fragment of the 
protein implying that any truncated protein retaining the N-terminal domain is absent in the iPSC-RPE 
from the RP patient. This data corroborates the patient-specific origin of generated iPSC-RPE monolay-
ers and additionally confirms the correct polarization of generated RPE cells.
Expression of MERTK and mature RPE specific markers was confirmed by western blot through-
out the differentiation process of two iPSC lines per genotype (Fig.  3C). The expression pattern of 
RPE-specific markers is matched with human RPE (hRPE) extract from cadaveric donor by loading the 
same total protein amount. Irrespective of the individual, whether healthy or RP patient, RPE-specific 
markers BEST1 and CRALBP are absent from fibroblasts and iPSCs but are detected in iPSC-RPE mon-
olayers at similar levels. MERTK is detected as a double band, which migrates with molecular weight of 
180 and 130 kDa in healthy individual’s monolayer and native RPE while being absent in iPSC-RPE from 
RP patient harboring the MERTK mutation. Human embryonic kidney cells (HEK 293T) are known to 
express MERTK28 as a single 180 kDa band while being negative for RPE markers. The MERTK expres-
sion is detected also in iPSC from control individual upon higher protein load (Supplementary Fig. S7). 
A 180 kDa band corresponding to MERTK is also described in human ESC and ESC-RPE7, supporting 
the view that MERTK is expressed in pluripotent stem cells and corroborating the identity of the 180 kDa 
band. The observed molecular weight of MERTK by western blotting does not correspond to the predic-
tive molecular weight of 110 kDa of the 999 amino acid long MERTK. The protein was detected at signif-
icantly larger sizes ranging from 165–205 kDa in different cell types due to posttranslational modification 
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Figure 3. For legend see next page.
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such as glycosyation (14 glycosylation sites are detected in UniProt database), ubiquitination or phos-
phorylation15,28. The two bands corresponding to 180 and 130 kDa peptides (Fig. 3C), demonstrate that 
these two isoforms are specific to RPE as confirmed in hRPE extract as opposed to a single 180 kDa 
band observed in HEK 293T cells. The western blot confirms the absence of MERTK and any truncated 
protein preserving the N-terminal domain (Supplementary Fig. S7) in RP-affected patient corroborating 
the identity of the patient-derived iPSC-RPE and indicating that the defective, kinase lacking, MERTK 
is probably degraded in patient’s RPE.
Patient’s iPSC recapitulate the disease phenotype. MERTK deficient phenotype described in 
animal models is defective phagocytosis, a daily process of OS uptake, which renews the light–damaged 
membranes of PR. The process of OS phagocytosis can be mimicked in cultured RPE cells by feeding the 
isolated OS derived from bovine or pig retina6,7. We exposed the cultured iPSC-RPE monolayers from 
both individuals to fluorescently labeled bovine and pig OS and monitored their ingestion by confocal 
imaging. Figure  4 shows the internalization of OS by the iPSC-RPE from the healthy individual while 
Figure 3. RPE characteristic marker gene and protein expression in iPSC-RPE from healthy individual 
and RP patient. (A. i) BEST1, CRALBP, RPE65, MERTK gene expression in fibroblasts, iPSCs and iPSC-
RPE. Two iPSC lines (iPSCc1 and iPSCc2) and their respective iPSC-RPE from each individual are analyzed. 
The samples were loaded on agarose gels prepared and run under the same experimental conditions.  
(ii) Quantitative reverse transcription polymerase chain reaction to analyze expression of genes characteristic 
for RPE. Fold expression in undifferentiated iPSCs and iPSC-RPE from healthy and MERTK p.Ser331Cysfs*5 
patient normalized to their originating dermal fibroblasts (DF). Each bar represents the average ± SEM 
of at least three independent biological replicates (* p ≤ 0.05, **p ≤ 0.05, ***p ≤ 0.05). (B. i) Expression of 
RPE characteristic proteins by iPSC-RPE. Immunocytochemistry against RPE65, CRALBP, BEST1, ZO-1 in 
healthy and MERTK p.Ser331Cysfs*5 iPSC-RPE. Images were taken with Leica confocal microscope TCS 
SP5 using HCX PL APO lambda blue 63X/ 1.4 OIL objective. Scale bar 10µm. (ii) MERTK expression in 
iPSC-RPE. Immunocytochemistry against MERTK. Apical section and vertical section simulation showing 
apical MERTK distribution in the healthy individual. MERTK p.Ser331Cysfs*5 iPSC-RPE stain negative for 
MERTK at all sections. Images were taken with Leica confocal microscope TCS SP5 using HCX PL APO 
lambda blue 63X/ 1.4 OIL objective, scale bar 10 μ m. (C). Western blot analyses of RPE-specific marker 
protein expression in fibroblasts (DF), two iPSC lines (iPSCc1 and iPSCc2) and their respective iPSC-RPE 
from each individual are analyzed. The expression of CRALBP and BEST1 is detected only in iPSC- RPE 
and hRPE cells. β actin was used as loading control. Cropped blots are from gels run under the same 
experimental conditions and loaded with the same samples.
Figure 4. In vitro phagocytosis assay of photoreceptor outer segments (OS) by iPS-RPE from healthy 
individual and MERTK p.Ser331Cysfs*5 patient. Basolateral sections across the iPSC-RPE cells together 
with vertical section simulation. Healthy iPS-RPE internalize FITC-labeled OS (green) while patient’s one 
do not. F-actin is stained by phalloidin (red) to visualize cell morphology. Images were taken with Leica 
confocal microscope TCS SP8 using HCX PL APO lambda blue 63X/ 1.4 OIL objective, scale bar 25 μ m.
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this was completely lacking in the case of the RPE generated from the RP patient. The labeled phalloidin 
depicts the abundant F-actin in the microvilli and the OS are detected in the region of microvilli and 
inside the cells derived from healthy individual. Vertical sectioning demonstrating the ingested OS pha-
gosomes inside the cells is shown on Supplementary Fig. S8. The patient’s iPSC-RPE monolayer showed 
only a few OS in the area of microvilli. Both iPS cell lines derived from the RP patient exhibited the same 
defect in phagocytosis of OS upon differentiation to RPE.
We have thus generated patient-specific RPE cells that lack the expression of MERTK and conse-
quently recapitulate the MERTK deficient phenotype i.e. absence of phagocytosis. These data show that 
patient-specific, mature and functional RPE can be generated from control and RP patients via iPSCs. 
The monolayers derived from the two individuals as reported here are morphologically identical and 
indistinguishable by RPE-specific marker expression while preserving patient’s identity as observed by 
distinctive MERTK expression and its associated function.
Discussion
Retinal dystrophies comprise a group of eye diseases caused by mutations in a spectrum of genes with 
a specific function in photoreceptors or RPE cells or in many cases mutations in ubiquitously expressed 
genes that exclusively give rise to a retinal phenotype. While retinal tissue is inaccessible for the studies 
of molecular mechanism, unrelated tissues such as blood is not truly representative of molecular events 
in the retina. Animal models remain an invaluable tool to understand disease mechanism, however in 
some cases they are not fully representative of the disease pathophysiology, owing to differences in neu-
ronal development, physiology and the genetic background. In some cases, such as the Usher-1 mouse 
model, the animal lacks the disease phenotype29, or the CHM gene deficient mice (model for choroi-
deremia) which are lethal30, iPSC-based models represent a viable alternative to study disease biology. 
Patient-specific iPSC offer a renewable cell source that can be coaxed toward a desired cell type, which 
offers a unique opportunity to gain valuable insight into the disease mechanism in addition to drug 
screening, toxicity testing and explore new therapies in the context of the human genetic background.
MERTK mutations account for approximately 1% of arRP and were reported in several families with 
retinal dystrophy20,31–35; with common clinical features such as early onset of symptoms, usually in the 
first decade of life, loss of peripheral vision as typically associated with rod-cone type of dystrophy and 
accumulation of OS by-product debris in the sub-retinal space detected by optical coherence tomogra-
phy. These clinical parameters can be used as distinctive features of MERTK-associated RP facilitating 
early identification of patients. Early detection of patients should provide a better choice of therapeutic 
options. Altogether 20 mutations have been described in the MERTK gene causing RP, the majority 
being missense/nonsense mutations (11), splicing-site mutations (3), small deletions (3), insertions (1) 
and gross deletions (2) as reported in the HGMD public database (last accessed January 8, 2015). We 
show here the successful generation of iPSC from a RP patient bearing a novel p.Ser331Cysfs*5 muta-
tion in MERTK which has not been described before. Adult dermal fibroblasts were reprogrammed 
with non-integrative virus delivering pluripotency genes and the generated iPSCs maintained genomic 
integrity throughout the culture period of over 30 passages. It should be noted that genomic alterations 
including numerical and structural alterations are not uncommon in iPSC cultures. In our experience 
the use of Sendai virus as a vehicle for gene delivery resulted in the absence of genomic alterations in 
contrast to integrative viral strategies. As demonstrated here, iPSCs established from the control and 
the affected patient were identical in relation to reprogramming efficiency and exhibited similar kinetics 
and efficiency of differentiation. Both iPSC-RPE were morphologically indistinguishable, the polygo-
nal morphology and pigmentation was displayed by control and patient RPE. The RPE specific marker 
expression such as CRALBP, RPE65, BEST1 and ZO-1 was similar in both iPSC-RPE monolayers. A 
distinctive functional feature of the native RPE is the cellular polarity based on the polarized localization 
of RPE markers. We show polarized distribution of ZO-1, a tight junction marker, and Na+/K+ ATPase 
pump protein expressed on the apical membrane. This is a distinctive RPE feature since Na+/K+ ATPase 
is reported to be expressed basolaterally in other transporting epithelia36. MERTK distribution is also 
shown to be apical as previously described in RPE cells27. Another RPE functional characteristic is the 
presence of tight junctions essential for the formation of blood-retina barrier. We observe by electron 
microscopy structures corresponding to tight junctions and apico-lateral localization of ZO-1 by fluo-
rescent microscopy. In conclusion it can be stated that MERTK deficiency does not interfere with these 
functional parameters.
In order to confirm that the difference between healthy and diseased cells is due to disease mutation 
and not due to inter-lineage variability described for iPSCs37,38 we studied in parallel two iPSC lines 
per individual. The disease-specific defect is then expected to be present in all disease iPSC lines while 
absent from all healthy iPSC lines which is confirmed by our findings. Analysis of the MERTK expression 
raises the possibility that the patient’s mRNA partially escapes nonsense–mediated decay and perhaps the 
transcript is translated into an abnormal 334 amino acid protein lacking the kinase domain. However, 
we do not detect the truncated protein in patient’s iPSC-RPE extracts by western blot nor by immuno-
cytochemistry in the iPSC-RPE monolayer, suggesting that it may be degraded after being translated.
Our results prove that patient-specific iPSC reproduce the disease phenotype reliably and this should 
allow faithful modeling of degenerative disease of the RPE in the future with more subtle phenotypes 
and completely unknown disease mechanisms. In addition, the generated iPSC-RPE represents clinically 
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reliable setting to test therapies in order to reverse or delay the disease onset in patients harboring 
MERTK mutations.
Materials and Methods
Genetic analysis. A consanguineous Spanish family (RP-0503) consisting of three affected siblings 
(Supplementary Fig. S1A) was recruited by the Fundacion Jimenez Diaz Hospital (Madrid, Spain). DNA 
was extracted from peripheral blood leukocytes collected in EDTA tubes using an automated DNA 
extractor (BioRobot EZ1; Qiagen; Hilden, Germany). Informed consent was obtained from all individ-
uals involved, all procedures were reviewed and approved by the Ethics Committee of the Fundacion 
Jimenez Diaz Hospital and adhered to the tenets of the Declaration of Helsinki.
Whole-genome single nucleotide polymorphism (SNP) microarray analysis was performed using 
Illumina HumanCyto-12 SNP array, containing 298,199 SNPs markers (Illumina, Inc, San Diego, CA). 
Arrays were processed according to the manufacturer’s protocols. Linkage analysis was performed, using 
the Gene Hunter program (version 2.1r5) in the easyLINKAGE plus software package (version 5.08), to 
identify regions that may contain the causative mutation. As the affected siblings were born of a consan-
guineous marriage, only the homozygous regions were taken into account.
Bidirectional automatic sequencing was performed to screen the MERTK gene for mutations. Exons 
and exon–intron boundaries of MERTK were analyzed using oligonucleotide primer pairs designed using 
Primer3 software (http://frodo.wi.mit.edu/). Sequences and annealing temperatures are available from 
the authors on request. The PCR conditions and primer sequences are available on request. The PCR 
products were enzymatically purified with ExoSAP-it (USB, Affymetrix) and both strands sequenced 
using Big Dye Terminator Cycle Sequencing Kit version 3.1 (Applied Biosystems, Carlsbad, CA). The 
PCR products were purified in a 96-well multiscreen filter plate (Montage SEQ96 Sequencing Reaction 
Cleanup Kit; Millipore, Bedford, MA) and resolved on an automated sequencer (ABI 3130xl Genetic 
Analyzer, Applied Biosystems).
Direct sequencing in fibroblasts and iPSCs: Genomic DNA from fibroblasts and iPSCs was isolated 
using the QIAamp DNA Blood mini kit (Quiagen). Primers used for amplification and directed sequencing 
of MERTK upstream and downstream of c.992_993 were as follows: 5′ CGAAGAGGTTCTAAGAGAGG3′ 
and 5′ CCATTTTCATCAGTCGCCTC3′ (annealing temperature 55 °C).
Derivation of skin fibroblasts. Skin biopsy of a healthy individual and an affected patient (with a 
confirmed molecular diagnosis of early-onset RP) was taken under sterile conditions following informed 
consent. The skin biopsy sample was placed in ~25 ml of sterile PBS at room temperature (20–25 °C) for 
shipment. Inside a tissue culture hood, the PBS was replaced with PBS containing 10× penicillin/strep-
tomycin (500 U/ml penicillin and 500 µg/ml streptomycin) and 10× Fungizone (25 µg/ml amphotericin 
B) and left at room temperature for 15 min, with occasional mixing by inverting the tube. This step was 
repeated twice and finally the biopsy sample was washed with PBS for 15 min. The sample was cut into 
small pieces and cultured in 60-mm plastic dishes (8–10 pieces per dish) in DMEM (10% FBS, 2 mM 
GlutaMAX, 50 U/ml penicillin and 50 mg/ml streptomycin) at 37 °C under 5% CO2. After 3–4 weeks, fibro-
blasts outgrowing from the biopsy pieces cover most of the dish and cells were passaged and plated in a 
T-75 flask. After reaching 80% confluency fibroblasts were further expanded and cryostored in liquid N2.
Generation and maintenance of iPSC lines. The iPSC were derived from patient’s fibroblasts using 
Sendai virus (Cytotune iPS reprogramming Kit, Life Technologies) according to manufacturer’s instruc-
tions. Single colony subcloning was performed for 5 passages and the presence of Sendai virus transgenes 
was detected by RT-PCR (Supplementary Fig. S2) with primers described in Supplementary Table S1, 
during passages 7–10. Cells set aside during reprogramming on day 7 were used as positive control. PCR 
was carried out using 500 ng of cDNA in the presence of MyTaq Red DNA Polymerase (Bioline) using 
manufacturer’s instructions. PCR products were analyzed using 2% agarose gel electrophoresis. iPSCs were 
grown on irradiated (45Gy) human foreskin fibroblasts (ATCC CRL 2429) in iPSCs medium containing 
KO DMEM, KSR 20%, Glutamax 2 mM, non essential aminoacids 0.1 mM, β -mercaptoethanol 0.23 mM, 
basic FGF 10 ng/mL, and peniciline/streptomicine. Cells were mechanically passaged every 6–8 days.
Differentiation toward RPE cells. To obtain RPE cells the iPSCs colonies were mechanically 
removed and cultured in low attachment plates as floating aggregates in the iPSC medium with 15% KSR 
and deprived of bFGF. When dark patches formed on the aggregates they were mechanically excised, 
treated with trypsin and plated on Matrigel (BD, #354277) coated plastic culture dishes. Depending on 
the confluency of plating, 3–5 weeks later, monolayers of cells with RPE characteristics (polygonal shape, 
pigmentation) appeared. After excising the aggregated portions, the RPE-like monolayer was dissociated 
with trypsin–EDTA (0.05%), passed through a 70 μ m strainer and plated at 200,000 cells/cm2 on Matrigel 
coated transwell inserts (Corning 3470, MilliCell). The RPE cells were cultured for 30–60 days until they 
reached high pigmentation. Two iPS cell lines per each genotype were induced to differentiate toward 
RPE and no differences were observed with respect to kinetics of differentiation, degree of pigmentation 
or characteristic RPE morphology between the iPS cell lines from one individual nor between healthy 
and affected genotype.
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Teratoma assay. For teratoma assay the colonies from a fully confluent 6-well plate were cut mechan-
ically and resuspended in 200 μ L of ihPSCs media and matrigel. The suspension was immediately injected 
into 5 week-old SCID nude mice subcutaneously on the dorsal part. After about 8 weeks, teratomas of 
1 cm diameter were formed and these were excised. Teratomas were fixed in 4% PFA for 3 days, washed 
3 times with PBS, sectioned in half and observed macroscopically for the presence of cysts. Then the 
samples were dehydrated using 70–80–95% ethanol and xylol and embedded in paraffin. Continuous 
6 μ m sections and hematoxilin/eosin staining were performed at the Histology Unit, CABIMER. Pictures 
were taken with Leica DM6000B, connected with Leica DFC 350 FX camera.
Phagocytosis assay. Photoreceptor OS were obtained from InVision BioResources (WA, USA) or pre-
pared in-house according to Molday et al., 198739. OS labeling: Two mg/ml stock solution of FITC isomer 
1 (F7250, Sigma) in 0,1M sodium bicarbonate at pH 9.0–9.5, was prepared, filter-sterilized, and stored 
in aliquots at −20 °C. For labeling with FITC, OS were suspended in solution containing 10% sucrose, 
20 mM sodium phosphate, and 5 mM taurine, and incubated with FITC for 1,5 h at room temperature, 
rotating in the dark. FITC-labeled OS were washed 5 times in buffer containing 10% sucrose, 20 mM 
sodium phosphate and 5 mM taurine, suspended in DMEM, aliquoted and stored at − 80 °C until use.
iPSC-RPE cells were incubated with OS for 2 h/37 °C, after which the OS were removed by triple wash-
ing with PBS. Cells were fixed by 4% PFA for 15 min/RT, washed and permeabilized by 0.1% Triton-X. 
Phallodin staining was performed for 30 min, the samples were then mounted with vectashield mounting 
media with DAPI. The samples were visualized by Leica confocal microscope TCS SP5 using HCX PL 
APO lambda blue 63X/ 1.4 OIL objective.
Transmission Electron Microscopy. RPE cultured cells were fixed in 4% paraformaldehyde, 2% glu-
taraldehyde in 0.1 M sodium phosphate buffer (pH 7,2–7,4) for 2 h, washed with the same buffer, and 
then postfixed in 1% OsO4 in PB. After gradual dehydration in ethanol series, the pieces were embedded 
in EPON 812. Semithin sections stained with 1% toluidine blue in 3% sodium tetra-borate were ana-
lyzed with a Leica DMR light microscope (Leica Microsystems). Semithin and ultrathin sections were 
obtained in an ultramicrotome (Leica Ultracut R, Leica Microsystem.). After staining with lead citrate 
and uranil acetate, ultrathin sections were examined in a JEM-1400 Plus electron microscope (JEOL 
GmbH, München, Germany).
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